“完美风暴”中的估值洼地！美银力荐这一被“错杀”的板块

Group 1 - The article discusses the impact of Trump's tariff policies on global markets, particularly highlighting the volatility in sectors sensitive to tariffs such as automotive, mining, and pharmaceuticals [1] - European pharmaceutical stocks are currently seen as undervalued despite the recent market turmoil, with the Stoxx Pharmaceuticals index down nearly 5% this year [1] - The market has overestimated the risks posed by Trump's tariffs to the pharmaceutical sector, particularly affecting companies like Novo Nordisk, which has seen its stock drop nearly 30% since the beginning of the year [1] Group 2 - The valuation gap between cyclical and defensive sectors in Europe has reached a 30-year high, indicating that not only pharmaceutical stocks but also food and beverage sectors are dragging down the Swiss market [2] - There is a potential for rich investment opportunities in the Swiss market's pharmaceutical, food, and beverage sectors if a global economic slowdown occurs [2]